Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Cutan Pathol ; 47(6): 554-560, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31995237

RESUMO

Liposarcomas are categorized into four distinct histopathological subtypes: atypical lipomatous tumors (ALT)/well-differentiated liposarcoma (WDL), dedifferentiated, myxoid, and pleomorphic. Dedifferentiated liposarcomas account for approximately 18% of all liposarcomas, characteristically arising in the deep soft tissue. They are reported to have lower rates of metastasis compared to other pleomorphic sarcomas.1 -3 The classic histopathologic appearance is ALT/WDL admixed or juxtaposed with a predominantly nonlipogenic sarcoma. Epithelioid features are rare, appearing in as few as 3% of tumors, and have not previously been reported in a superficial location. Herein, we present a 57-year-old male with intradermal and subcutaneous metastasis of his known deep dedifferentiated liposarcoma with epithelioid features. By H&E the tumor featured cords and sheets of crowded, plump, epithelioid cells with thick nuclear membranes and prominent nucleoli, which raised a broad differential including carcinoma and melanoma. By immunohistochemistry the tumor was diffusely positive for MDM2 and CDK4, on the other hand stains for Sox10, Melan A, MITF, CKAE1/3, desmin, and S100 protein were negative. This case serves as an opportunity to raise awareness of this rare morphological subtype, which can involve the skin and mimic epithelial and melanocytic malignancies. It can be a potential diagnostic pitfall, especially if metastases are the first presentation.


Assuntos
Células Epitelioides/patologia , Lipossarcoma/metabolismo , Neoplasias Cutâneas/patologia , Neoplasias de Tecidos Moles/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Quinase 4 Dependente de Ciclina/metabolismo , Diagnóstico Diferencial , Doxorrubicina/uso terapêutico , Evolução Fatal , Feminino , Humanos , Imuno-Histoquímica/métodos , Lipossarcoma/diagnóstico , Lipossarcoma/tratamento farmacológico , Lipossarcoma/cirurgia , Perda de Seguimento , Masculino , Pessoa de Meia-Idade , Metástase Neoplásica/patologia , Proteínas Proto-Oncogênicas c-mdm2/metabolismo , Tela Subcutânea/patologia , Inibidores da Topoisomerase II/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA